C0008976||trial
C0036983||septic shock
C0034656||randomized
C1271494||goal-directed fluid-sparing strategy
C0008976||SQUEEZE
C2348563||study protocol
C0206035||pilot randomized controlled trial
C0036983||septic shock
C0035273||resuscitation
C0162791||guidelines
C1708333||American College of Critical Care Medicine
C1271494||goal-directed administration
C0442123||intravascular
C0005889||fluid
C0013227||medication
C0574032||infusions
C0349412||fluid-refractory shock
C4055506||accumulating
C0522792||fluid administration
C1457868||worse
C2749787||increased risk of death
C0442123||intravascular
C0005889||fluid
C0036983||septic shock
C0035273||resuscitation
C0008976||SQUEEZE Pilot Trial
C0242481||two-arm
C2826345||parallel-group
C1709323||open-label
C0206035||prospective pilot randomized controlled trial
C0679646||Participants
C0750484||confirmed
C0036983||septic shock
C0035273||resuscitation
C0679646||participants
C1516879||enrolled
C0035273||Fluid Sparing (intervention) resuscitation strategy
C0018017||objective
C0008976||pilot trial
C0015730||feasibility
C1516879||enroll
C0679646||participants
C2348563||study protocol
C0679646||participant
C1516879||enrollment
C0679646||participants
C0205145||site
C1516879||enrollment
C0018017||objectives
C0206012||multisite trial
C0008972||nested translational study
C0008972||SQUEEZE-D
C0015730||feasibility
C4289789||cell-free DNA
C1292267||procoagulant molecule
C0220901||prognostic utility
C0178913||blood samples
C1516879||enrolled
C0008976||SQUEEZE Pilot Trial
C0005889||fluid
C0035273||resuscitation
C0036983||septic shock
C0033522||prospective study
C1522634||question
C0006823||Canada
C0008976||SQUEEZE Pilot Trial
C0243095||Findings
C0015730||feasibility
C0206012||multicenter trial